Tristel (LON:TSTL) Shares Up 3.3% – Here’s What Happened

Tristel plc (LON:TSTL)’s share price rose 3.3% on Thursday . The company traded as high as GBX 404.95 ($5.11) and last traded at GBX 395 ($4.99). Approximately 46,028 shares were traded during mid-day trading, a decline of 31% from the average daily volume of 66,706 shares. The stock had previously closed at GBX 382.50 ($4.83).

Tristel Stock Performance

The stock has a 50-day simple moving average of GBX 403.86 and a 200-day simple moving average of GBX 433.42. The stock has a market cap of £185.84 million, a PE ratio of 3,000.00 and a beta of 0.23. The company has a debt-to-equity ratio of 19.12, a current ratio of 4.92 and a quick ratio of 3.83.

Tristel Increases Dividend

The firm also recently announced a dividend, which will be paid on Friday, December 20th. Investors of record on Thursday, November 28th will be given a dividend of GBX 8.28 ($0.10) per share. This represents a yield of 2.1%. The ex-dividend date is Thursday, November 28th. This is an increase from Tristel’s previous dividend of $5.24. Tristel’s dividend payout ratio is 10,000.00%.

Insider Buying and Selling at Tristel

In related news, insider Elizabeth Dixon sold 50,000 shares of the stock in a transaction on Thursday, September 19th. The stock was sold at an average price of GBX 397 ($5.01), for a total value of £198,500 ($250,536.41). 4.89% of the stock is currently owned by corporate insiders.

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.